IP Library Granted Patent US 11,850,219
Granted Patent B2
US 11,850,219 · App. 17/373,731 · Granted Dec 26, 2023

Inositol-stabilized arginine-silicate for hair growth and thickening

Inventor: James R. Komorowski (Trumbull, CT)
Assignee: Nutrition21, LLC
A61K31/155A61K31/7004A61K33/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,850,219
App. No.
17/373,731
Granted
Dec 26, 2023
Kind
B2
Abstract

The present invention generally relates to compositions and methods for topical or transdermal delivery, for promoting wound healing, reducing scarring, and/or promoting hair growth. Specifically, the present disclosure is directed to a topical arginine silicate formulation that demonstrates surprising improvements in promoting hair growth.

Claims (24)

1. A method for promoting hair growth comprising:

orally administering a daily dose of a hair growth composition comprising inositol-stabilized arginine silicate to a human in need thereof;

wherein the daily dose comprises about 1.0 mg to about 5.0 mg of the inositol-stabilized arginine silicate per kilogram of the human's body weight.

2. The method of claim 1 , wherein the inositol-stabilized arginine silicate is between about 1% and about 10% by total weight of the hair growth composition.

3. The method of claim 2 , wherein the inositol-stabilized arginine silicate is about 4% by total weight of the hair growth composition.

4. The method of claim 2 , wherein the inositol-stabilized arginine silicate is 4.4% by total weight of the hair growth composition.

5. A method for increasing hair thickness comprising:

orally administering a daily dose of a hair thickening composition comprising inositol-stabilized arginine silicate to a human in need thereof;

wherein the daily dose comprises about 1.0 mg to about 5.0 mg of the inositol-stabilized arginine silicate per kilogram of the human's body weight.

6. The method of claim 5 , wherein the inositol-stabilized arginine silicate is between about 1% by total weight and about 10% of the hair thickening composition.

7. The method of claim 6 , wherein the inositol-stabilized arginine silicate is about 4% by total weight of the hair thickening composition.

8. The method of claim 6 , wherein the inositol-stabilized arginine silicate is 4.4% by total weight of the hair thickening composition.

9. The method of claim 1 , wherein the hair growth composition comprises a second active ingredient.

10. The method of claim 5 , wherein the hair thickening composition comprises a second active ingredient.

11. The method of claim 1 , wherein the subject is a female human.

12. The method of claim 5 , wherein the subject is a female human.

13. The method of claim 1 , wherein the method promotes hair growth in a shaved area.

14. The method of claim 1 , wherein the method increases the rate of hair growth.

15. The method of claim 1 , wherein the daily dose comprises about 1.0 mg, about 2.0 mg, about 3.0 mg, about 4.0 mg, or about 5.0 mg of the inositol-stabilized arginine silicate per kilogram of the subject's body weight.

16. The method of claim 5 , wherein the daily dose comprises about 1.0 mg, about 2.0 mg, about 3.0 mg, about 4.0 mg, or about 5.0 mg of the inositol-stabilized arginine silicate per kilogram of the subject's body weight.

17. The method of claim 1 , wherein the daily dose comprises about 1.0 mg to about 3.0 mg of the inositol-stabilized arginine silicate per kilogram of the subject's body weight.

18. The method of claim 5 , wherein the daily dose comprises about 1.0 mg to about 3.0 mg of the inositol-stabilized arginine silicate per kilogram of the subject's body weight.

19. The method of claim 1 , wherein the daily dose comprises about 2.0 mg of the inositol-stabilized arginine silicate per kilogram of the subject's body weight.

20. The method of claim 5 , wherein the daily dose comprises about 2.0 mg of the inositol-stabilized arginine silicate per kilogram of the subject's body weight.

Assignments (3)
SECURITY INTEREST Recorded Nov 9, 2021
From: NUTRITION 21, LLC
To: CAPITAL ONE, NATIONAL ASSOCIATION, AS AGENT
Reel/Frame 058060/0535 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 20, 2021
From: KOMOROWSKI, JAMES R.
To: JDS THERAPEUTICS, LLC
Reel/Frame 057245/0834 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 20, 2021
From: JDS THERAPEUTICS, LLC
To: NUTRITION 21, LLC
Reel/Frame 057246/0001 →
Continuity (3)
Continuation 15348188 · Nov 10, 2016
Provisional Application 62254314 · Nov 12, 2015
Related Publication 20210338606A1 · Nov 4, 2021
Cited By (1)
US 12,257,238